• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Empowering Pharmacy Technicians to Lead: Advocacy and Preparation for Career Growth

by MM360 Staff | May 28, 2025 | Myeloma News

Source: Pharmacy Times articles Real change often begins within pharmacies. Read More

Neoadjuvant Efti/Keytruda Combo Improves Tumor Fibrosis Rates in Sarcoma

by MM360 Staff | May 28, 2025 | Uncategorized

Source: CureToday articles Neoadjuvant efti and Keytruda plus radiotherapy met the EFTISARC-NEO trial’s primary end point by improving tumor fibrosis in soft tissue sarcoma. Read More

The Intersection of Pharmacists and Biotechnology: Advancements and Challenges

by MM360 Staff | May 28, 2025 | Myeloma News

Source: Pharmacy Times articles Pharmacists have an evolving role in biotechnology. Read More

The efficacy of new drug regimens in treating newly diagnosed high-risk cytogenetic multiple myeloma patients: a systematic literature review and meta-analysis

by MM360 Staff | May 28, 2025 | Publications

Front Med (Lausanne). 2025 May 13;12:1575914. doi: 10.3389/fmed.2025.1575914. eCollection 2025. ABSTRACT INTRODUCTION: Multiple myeloma (MM) is a plasma cell malignancy comprising 10% of hematologic cancers, associated with bone marrow dysfunction and organ damage....

FDA Approves Ustekinumab-hmny Injection, a Biosimilar Referencing Stelara

by MM360 Staff | May 28, 2025 | Myeloma News

Source: Pharmacy Times articles A new biosimilar to ustekinumab (Stelara) has been approved by the FDA, further expanding treatment options for patients with immune conditions such as plaque psoriasis and psoriatic arthritis. Read More
« Older Entries
Next Entries »

Recent Content

  • Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study
  • Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma
  • Subcutaneous Darzalex Faspro Extends PFS in Smoldering Myeloma
  • A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients
  • Subcutaneous Bortezomib Associated With Reduced Incidence of Peripheral Neuropathy in Multiple Myeloma
  • Multiple Myeloma: Key Insights on Diagnosis and Evolving Treatment Strategies
  • Multiple myeloma associated long non-coding RNA PLUM confers chemoresistance by enhancing PRC2 mediated UPR pathway activation
  • Mobilization of hematopoietic stem cells using G-CSF with or without cyclophosphamide before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma receiving induction therapy with or without daratumumab
  • Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study
  • The long non-coding RNA CRNDE stabilises SIRT1 protein and influences Hedgehog signalling in multiple myeloma
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT